Market Research Reports and Industry Reports

Mallinckrodt LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imaging, nuclear imaging and contrast media and devices. Its generic products include addiction treatment products, compounding powders, unit dose products, and resource tool kit, among others. Mallinckrodts specialty brands and generics segments commercializes in the areas of neurology, nephrology, rheumatology, ophthalmology, pulmonology, rare disease products, and others. The company provides treatment to health conditions including pain, central nervous system disorders, autoimmune and rare diseases. The company has its presence in the US, the UK and Ireland. Mallinckrodt is headquartered in St. Louis, Missouri, the US.

Mallinckrodt LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
Venture Financing 12
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Partnerships 13
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Licensing Agreements 17
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Acquisition 18
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt LLC - Key Competitors 20
Mallinckrodt LLC - Key Employees 21
Mallinckrodt LLC - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables

List of Tables
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Key Facts 2
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt LLC, Key Competitors 20
Mallinckrodt LLC, Key Employees 21
Mallinckrodt LLC, Subsidiaries 22

List Of Figures

List of Figures
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt LLC, Medical Devices Deals, 2011 to YTD 2017 9

Mallinckrodt, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging

USD 250View Report

Mallinckrodt LLC - Medical Equipment - Deals and Alliances Profile

Mallinckrodt LLC (Mallinckrodt), formerly Therakos, Inc., a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis (ECP). It offers Therakos CELLEX Photopheresis system, which

USD 250View Report

Rockies Standard Oil Company LLC - Oil & Gas - Deals and Alliances Profile

Rockies Standard Oil Company LLC (RSOC) is an oil and gas service provider that offers exploration services for oil and gas projects in the Rockies. The company undertakes projects such

USD 250View Report

Sempra U.S. Gas & Power LLC - Oil & Gas - Deals and Alliances Profile

Sempra U.S. Gas & Power, LLC (Sempra US), a subsidiary of Sempra Energy, an energy solution provider, is a clean power solutions developer. It develops, designs, constructs and operates renewable

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2017
No. of Pages :23
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube